SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-12-023637
Filing Date
2012-05-08
Accepted
2012-05-08 16:33:24
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 ANTARES PHARMA, INC 10-Q 3-31-2012 form10q.htm 10-Q 416346
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 14301
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 14311
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 7372
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 7416
  Complete submission text file 0001140361-12-023637.txt   1650634

Data Files

Seq Description Document Type Size
6 INSTANCE DOCUMENT ais-20120331.xml EX-101.INS 143763
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ais-20120331.xsd EX-101.SCH 11739
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT ais-20120331_cal.xml EX-101.CAL 34142
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ais-20120331_lab.xml EX-101.LAB 137808
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ais-20120331_pre.xml EX-101.PRE 79099
Mailing Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618
Business Address 250 PHILLIPS BLVD SUITE 290 EWING NJ 08618 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1208
Type: 10-Q | Act: 34 | File No.: 001-32302 | Film No.: 12821843
SIC: 3841 Surgical & Medical Instruments & Apparatus